Vertex Has A Lot Riding On Alyftrek, Journavx — And Investors Are Watching Closely – Vertex Pharmaceuticals (NASDAQ:VRTX)
Vertex Pharmaceuticals Inc VRTX is entering earnings week with some serious anticipation — and a bit of heartburn. The stock had a solid run in 2025, up nearly 20% year-to-date and 21% over the past 12 months. But with a 3.5% pullback in the past …